Search the Newsreel

Enovix Corp (ENVX) CLO withholds 2,221 shares to cover RSU taxes

Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, had 2,221 shares withheld on July 24, 2026, at $3.95 per share to cover tax obligations from vesting Restricted Stock Units (RSUs). After this transaction, Chakravarthy directly holds 584,471 shares, which includes RSUs and Performance Restricted Stock …

UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating

UBS has increased its price target for Enovis (NYSE: ENOV) to $51, up from $50, while reaffirming its Buy rating on the stock. This adjustment reflects a continued positive outlook from the firm regarding Enovis's financial prospects and market position.

Enova International, Inc. (ENVA) Hits Fresh High: Is There Still Room to Run?

Shares of Enova International (ENVA) have been strong performers lately, with the stock up 6.9% over the past month. The stock hit a new 52-week high of $252.71 in the previous session. Enova International has gained 60.3% since the start of the year compared …

The Manufacturers Life Insurance Company Increases Stake in Cenovus Energy Inc $CVE

The Manufacturers Life Insurance Company increased its stake in Cenovus Energy Inc (NYSE:CVE) by 13.6% in the first quarter, acquiring an additional 2.12 million shares, bringing its total holdings to approximately 17.73 million shares. This move values their investment at $470.12 million and represents …

Enovix Corp (ENVX) Institutional Confidence

The article details the institutional confidence score for Enovix Corp (ENVX), which is currently 5.00, ranking 117th in its industry. It highlights that the institutional shareholding proportion has increased by 5.58% quarter-over-quarter to 51.83%. The largest institutional shareholder is Paul Tudor Jones, and the …

Enovis Market Sentiment

The article provides an overview of market sentiment for Enovis (ENOV), including analyst consensus, short interest, and recent analyst actions. It highlights a "Buy" consensus from 17 analysts with an average price target of $52, and notes a 19.7% rising short float, indicating bearish …

Renaissance Technologies LLC Trims Holdings in Cenovus Energy Inc $CVE

Renaissance Technologies LLC significantly reduced its stake in Cenovus Energy Inc. by 72.9% in the first quarter, selling over 3.8 million shares. Despite this, institutional investors collectively own a majority of the company's stock, and analysts largely maintain a "Buy" rating for Cenovus Energy …

Healthcare of Ontario Pension Plan Trust Fund Sells 14,895,479 Shares of Cenovus Energy Inc $CVE

The Healthcare of Ontario Pension Plan Trust Fund significantly reduced its stake in Cenovus Energy Inc. ($CVE) by selling nearly 14.9 million shares, representing a 96.6% decrease in its holdings. Despite this large sale by one institutional investor, Cenovus Energy reported strong quarterly earnings, …

RNXT Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Continues R&D Investment - Earnings Whisper Number

Does Enova International’s (ENVA) EPS Lift and Buyback Activity Reveal a Deeper Capital Allocation Shift?

Enova International (ENVA) recently reported strong Q2 2026 results, with revenue of US$568.07 million and net income of US$105.06 million. The company also continued its share buyback program, repurchasing 344,645 shares for US$51.77 million, which contributed to higher earnings per share. This activity suggests …

RenovoRx Inc (RNXT) Income Statement

This article provides the quarterly and annual income statements for RenovoRx Inc (RNXT), detailing financial performance metrics such as total revenue, operating expenses, operating profit, and net income. It also includes FAQs explaining how to interpret the income statement and highlights key financial figures …

RNXT|RenovoRx Inc|Price:0.959|Chg%:+0.093

RenovoRx, Inc. is a clinical and commercial biopharmaceutical company focused on oncology. Their primary product, RenovoCath, is a local drug delivery device, and they are evaluating a novel Phase III drug-device combination (intra-arterial gemcitabine, IAG) for pancreatic cancer. The article provides company details, executive …

Cenovus Energy Inc (CVE) Stock Down 4.2% but Still Overvalued -- GF Score: 59/100

Cenovus Energy Inc (CVE) shares dropped 4.2% to $28.04 on July 27, 2026, yet the stock is considered 73.0% overvalued according to its GF Value™ of $16.21. The company's GF Score™ of 59/100 indicates average overall performance with strong profitability but weak valuation and …

Snap Stock And Two Penny Shares With Stronger Balance Sheets

This article examines three penny stocks—Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN)—identified by the Financially Fit Penny Stocks screener, which focuses on companies with stronger balance sheets. It highlights their overview, operations, market cap, and investment cases, noting both their potential and associated …

CVE|Cenovus Energy Inc|Price:29.770|Chg%:-0.070

Cenovus Energy's Q2 Earnings on Deck: Should You Bet on the Stock?

Cenovus Energy (CVE) is slated to release its second-quarter 2026 earnings on July 29, with analysts predicting a significant increase in earnings per share and revenue. Despite having a strong track record of beating earnings estimates, the company's current Earnings ESP suggests it may …

Enova International Inc (ENVA) Cash Flow

This article provides a detailed cash flow statement for Enova International Inc (ENVA), presenting quarterly and annual data for operating, investing, and financing cash flows. It includes a multi-year breakdown of various cash flow components and offers definitions for key metrics like operating cash …

ENVA Q2 Deep Dive: Originations Growth, Margin Expansion, and Grasshopper Integration Plans

ENVA Q2 Deep Dive: Originations Growth, Margin Expansion, and Grasshopper Integration Plans Financial technology company Enova International (NYSE:ENVA) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 21.6% year on year to $928.9 million. Its non-GAAP profit of $4.31 per …

Interesting CVE Put And Call Options For November 2027

Investors in Cenovus Energy Inc (Symbol: CVE) saw new options become available today, for the November 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 480 days …

Enovix Corp (ENVX) Income Statement

This article provides the quarterly and annual income statements for Enovix Corp (ENVX), allowing users to analyze the company's financial performance and operational efficiency. It details various financial metrics including revenue, cost of revenue, operating expenses, and net income over several fiscal quarters and …

RenovoRx Inc (RNXT) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides dividend and stock split information for RenovoRx Inc (RNXT), noting that the company has not distributed any dividends over the past five years. It shows a market capitalization of $42.36 million and the stock price performance at the time of publication. …

RenovoRx Inc (RNXT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of RenovoRx Inc (RNXT), listing major individual and institutional holders and their respective proportions. It also breaks down shareholder types, including private equity, investment advisors, and individual investors, and provides a quarterly overview of institutional shareholding changes.

Enovis Corp (ENOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Cenovus Energy Inc (CVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Cenovus Energy Inc (CVE) by business segment and region, presenting data in USD. For business segments, Crude Oil, Gasoline, and Diesel and Distillate are the largest contributors. Regionally, the United States and Canada account for the …

ENOV|Enovis Corp|Price:27.030|Chg%:+0.990

Enovis Corp is a medical technology company specializing in reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through two segments, Prevention & Recovery and Reconstructive, offering a range of medical devices and solutions. Key executives, shareholding information, institutional holdings, and revenue …

Snap Stock And Two Financially Strong Penny Stocks Worth A Closer Look

This article highlights three financially strong penny stocks identified by Simply Wall St: Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN). Each company, despite being lower-priced, is presented with an overview of its operations, market cap, and future prospects, along with associated risks and …

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (ENVA) stock rallied over 9% after reporting strong Q2 2026 earnings, beating analyst expectations for EPS and revenue. Several analysts, including Citizens and Jefferies, raised their price targets, citing improved credit demand, stable performance, and the anticipated synergies from the Grasshopper …

RenovoRx, Inc. Revenue Breakdown – NASDAQ:RNXT

RenovoRx, Inc. (NASDAQ: RNXT) generated $1.12 million USD last year, primarily from its Oncology Therapies segment, which accounted for the entire sum. The United States was the sole geographic contributor to this revenue, also totaling $1.12 million. This indicates a significant increase from the …

Enova International Stock Jumps After Powerful Q2 Beat

Enova International (ENVA) stock surged 9.04% after reporting a strong Q2 2026 beat, with adjusted EPS of $4.31 surpassing consensus and revenue climbing to $928.9 million. This performance led analysts to raise price targets, citing higher earnings potential and strategic acquisitions. The company's profitability, …

TradingKey

This article provides a detailed cash flow statement for RenovoRx Inc (RNXT), breaking down operating, investing, and financing cash flows both quarterly and annually. It also includes frequently asked questions about different types of cash flow, such as operating, investing, financing, and free cash …

Bank of New York Mellon Corp Boosts Stock Position in Cenovus Energy Inc $CVE

Bank of New York Mellon Corp increased its stake in Cenovus Energy Inc. by 12% in the first quarter, acquiring an additional 165,987 shares and bringing its total holdings to 1,551,366 shares valued at approximately $41.2 million. This comes after Cenovus Energy reported strong …

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

RNXT|RenovoRx Inc|Price:1.120|Chg%:-0.030

RenovoRx, Inc. is a clinical and commercial biopharmaceutical company focused on oncology. Their primary product, RenovoCath, is a local drug delivery device, and they are evaluating a novel Phase III drug-device combination (intra-arterial gemcitabine, IAG) for pancreatic cancer. The article provides company details, executive …

Granahan Investment Management LLC Cuts Stock Position in Enovix Corporation $ENVX

Granahan Investment Management LLC reduced its stake in Enovix Corporation (NASDAQ:ENVX) by 19.1% during the first quarter, selling 374,979 shares and retaining 1,589,586 shares valued at approximately $8.23 million. Other institutional investors also adjusted their positions, with over 50% of Enovix shares now held …

3 Penny Stocks With Stronger Balance Sheets Than Many Early Stage Peers

This article identifies three penny stocks—Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN)—that exhibit stronger balance sheets compared to many early-stage peers, according to Simply Wall St's Financially Fit Penny Stocks screener. It highlights each company's operations, market cap, and investment appeal, while also …

Enova International, Inc. (NYSE:ENVA) Receives Average Rating of "Moderate Buy" from Analysts

Enova International, Inc. (NYSE:ENVA) has an average analyst rating of "Moderate Buy" from nine brokerages, with an average 12-month price target of $246.67. The company recently reported strong Q2 results, beating EPS and revenue expectations with significant year-over-year growth. Despite the positive earnings, the …